Learn more

INHIBITEX INC

Overview
  • Total Patents
    87
  • GoodIP Patent Rank
    236,459
About

INHIBITEX INC has a total of 87 patent applications. Its first patent ever was published in 1998. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are KARYON CTT LTD, BIOTEST AG and IMMUNOGEN INC.

Patent filings per year

Chart showing INHIBITEX INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Patti Joseph M 55
#2 Foster Timothy J 30
#3 Hutchins Jeff T 26
#4 Hook Magnus 24
#5 Domanski Paul 22
#6 Vernachio John 17
#7 Hall Andrea 15
#8 Patel Pratisksha 15
#9 Speziale Pietro 14
#10 Roche Fiona 9

Latest patents

Publication Filing date Title
EP2776438A1 Substituted purine nucleosides, phosphoramidate and phosphordiamidate derivatives for treatment of viral infections
WO2013066991A1 Crystalline solvates of nucleoside phosphoroamidates, their stereoselective preparation, novel intermediates thereof, and their use in the treatment of viral disease
WO2012092484A2 Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections
WO2012048013A2 Phosphorodiamidate derivatives of guanosine nucleoside compounds for treatment of viral injections
CN102464691A Method for preparing antiviral composition and application of intermediate thereof
CN102443032A Method for preparation of antiviral composition and application of intermediate thereof
BRPI1004575A2 compound, pharmaceutical composition, method of treating viral infections, phosphorus diastereomers separation method
WO2008089476A1 Monoclonal antibodies recognizing the enterococcus faecium acm protein
WO2007126813A2 Cross-reactive monoclonal antibodies recognizing als family proteins
WO2006138627A2 Monoclonal antibodies recognizing a coagulase-negative staphylococcal protein
EP1631581A2 Sdr proteins from staphylococcus capitis and their use in preventing and treating infections
WO03076470A1 Monoclonal and polyclonal antibodies recognizing coagulase-negative staphylococcal proteins
AU2002322127B2 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
CN1489474A Monoclonal antibodies to CLFA protein and method of use in treating or preventing
AU2443702A Monoclonal antibodies to the map protein and method of use in treating or preventing infections
WO0170267A1 Cross-reactive displacing antibodies from collagen-binding proteins and method of identification and use
AU5696699A Staphylococcal immunotherapeutics via donor selection and donor stimulation
AU5588999A Multicomponent vaccines
US6703025B1 Multicomponent vaccines
US6692739B1 Staphylococcal immunotherapeutics via donor selection and donor stimulation